- Abstract:
-
Cervical cancer is attributable to continuous expression of the E6 and E7 oncoproteins of the high-risk human papillomaviruses. These proteins target p53 and members of the retinoblastoma cellular regulatory protein family respectively for degradation, disrupting cellular control over apoptosis, senescence and the cell cycle. Delivery of short interfering RNAs (siRNAs) targeting mRNA from the HPV16 E6/E7 open reading frame to HPV16-positive cell lines, led to an 80% reduction in full-length t...
Expand abstract - Publication status:
- Published
- Journal:
- Cancer gene therapy
- Volume:
- 16
- Issue:
- 10
- Pages:
- 764-775
- Publication date:
- 2009-10-05
- DOI:
- EISSN:
-
1476-5500
- ISSN:
-
0929-1903
- URN:
-
uuid:86433e86-8124-49b9-9cdc-c14dbbd56817
- Source identifiers:
-
178824
- Local pid:
- pubs:178824
- Language:
- English
- Keywords:
- Copyright date:
- 2009
Journal article
Paclitaxel combined with siRNA targeting HPV16 oncogenes improves cytotoxicity for cervical carcinoma.
Actions
Authors
Bibliographic Details
Item Description
Terms of use
Metrics
Altmetrics
Dimensions
If you are the owner of this record, you can report an update to it here: Report update to this record